On October 10, 2014, FDA approved HARVONI a fixed-dose combination tablet of ledipasvir 90 mg, a hepatitis C virus (HCV) NS5A inhibitor, and sofosbuvir 400 mg, an HCV nucleotide analog NS5B polymerase inhibitor. Harvoni is indicated for the treatment of chronic hepatitis C (CHC) ...
Archive for category: News
A network building capacity to prevent, manage and treat hepatitis B and C in NYC
General News
The draft clinical criteria for the use of Hep C medication Sofosbuvir (Sovaldi) was presented to the NYS Department Of Health Drug Utilization Review Board (DURB) on Thursday, September 18, 2014.
Governor Andrew M. Cuomo today signed into law a bill that increases access to hepatitis C, or HCV, tests by allowing physicians and nurse practitioners to authorize registered nurses, when appropriate, to administer the test to a patient without the need for a patient-specific o...
A coalition of leading hepatitis C advocacy organizations and medical experts today called on Health and Human Services Secretary Sylvia Mathews Burwell to take leadership in eliminating harmful and discriminatory barriers to hepatitis C treatment access.
$ Focus Group | Hep C+ Women Age 40-49: Treated Not Cured or Currently Not On Treatment ($150/2 hours)
NewsRRU Research is seeking participants for a 2 hour focus group .
Presidential Proclamation | World Hepatitis Day 2014
News, Hepatitis B, Hepatitis C, World Hepatitis DayPresidential Proclamation | World Hepatitis Day 2014 See original post here. – – – – – – – BY THE PRESIDENT OF THE UNITED STATES OF AMERICA A PROCLAMATION Around the world, one in twelve people are living with viral hepatitis. In the Unit...
The Council of the City of New York Proclamation Whereas: Hepatitis B is a silent epidemic that affects 1.2 million Americans, most of whom do not know they are infected with the virus. Chronic hepatitis B can damage the liver for up to 20-30 years without symptoms, and can lead ...
State health departments receive less than $1 dollar in federal funding for every person living with viral hepatitis for the Viral Hepatitis Prevention Coordinator (VHPC) program.
The New York City Department of Health and Mental Hygiene is currently completing the first segment of a project that aims to gather support for the hepatitis B birth dose in New York City.
Project INSPIRE — CMS-funded Innovations Award Summary: The NYC Department of Health has announced the receipt of a new grant from the Federal government to improve treatment for hepatitis C. The grant will allow the Health Department, in conjunction with the Fund for Public He...